Tracey O’Brien: Collaboration between UNSW and Cancer Council NSW
Tracey O’Brien shared a post by on LinkedIn:
“Terrific to see this collaboration and significant investment in cancer survivorship research between UNSW and Cancer Council NSW. The Cancer Institute NSW looks forward to partnering with researchers to improve outcomes for people of NSW diagnosed with cancer.”
Quoting
“Today is an exciting day for cancer survivorship research, as we announced our 10-year partnership with UNSW to establish an Australian-first research centre for cancer survivors, the Australian Research Centre for Cancer Survivorship.
This is a pivotal moment in our work to tackle cancer, and improve the lives of cancer survivors as outlined in our current 5-year strategy. The launch of the Australian Research Centre for Cancer Survivorship is a vital step as we work to ensure better support, better care and ultimately a better quality of life for cancer survivors, through an evidence-based approach and world-class researchers.
You can learn more here.”
Source: Tracey O’Brien/LinkedIn and
Dr. Tracey O’Brien is the NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, Australia. Before her current role, Tracey was Director of the Kids Cancer Centre, Sydney Children’s Hospital, and Director of the Transplant & Cellular Therapy Program. Tracey has held numerous high-profile national and international leadership positions, including Advisory Chair, Cancer Australia; V/Chair (Africa, Asia and Australasia) International Centre for Bone Marrow Transplant Research and V/President of the Australian and New Zealand Children’s Oncology Group. In recognition of her exceptional contributions, Tracey was profiled in 2023 as one of the world’s foremost women in paediatric cancer by the International Society of Paediatric Oncology.
OncoDaily
In 2019 Tracey was named in the Australian Financial Review’s prestigious Top 10 Women of Influence, winning the Innovation category. In addition to her medical expertise, Tracey has a Master of Law (Health) and executive MBA and serves as a conjoint Professor in Clinical Medicine (UNSW) and Honorary Professor in Science and Engineering (Macquarie University). Dr. O’Brien remains committed to mentoring the next generation of clinician leaders and maintains an active clinical practice in cancer survivorship at Sydney Children’s Hospital.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023